{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:30Z","timestamp":1787027010191,"version":"build-2736575974"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"\n Context<\/jats:title>\n Type 2 diabetes (DM2) is an emerging disease in the pediatric population. DM2 is associated with metabolic-associated fatty liver disease (MAFLD). High-density lipoproteins (HDLs) are lipoproteins that are believed to have atheroprotective properties that reduce the risk of cardiovascular disease (CVD). Current evidence suggests that the physicochemical and functional features of HDLs may play a key role in the pathogenesis of atherosclerosis.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n We aimed to assess the impact of MAFLD on cholesterol efflux capacity (CEC) in adolescents with DM2.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A cross-sectional study.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Attention clinic for Children with Diabetes of the Hospital Infantil de M\u00e9xico Federico G\u00f3mez.<\/jats:p>\n <\/jats:sec>\n \n Patients or other participants<\/jats:title>\n This study included a total of 70 adolescents, 47 of which had DM2 and 23 were healthy individuals.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n The presence of MAFLD was determined by MR spectroscopy with proton density fat fraction. We compared the distribution of HDL subtypes (HDL2b, HDL2a, HDL3a, HDL3b, and HDL3c) and the chemical composition of HDLs (total protein, triglycerides, phospholipids, cholesteryl esters, and free cholesterol). HDL functionality was determined by the CEC, measuring the fluorescent cholesterol efflux from J774 macrophage cells.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n We were expecting to observe a decrease in HDL efflux capacity in adolescents with type 2 diabetes and MAFLD.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In our study, we observed a prevalence of MAFLD in 66% of adolescents with DM2, similar to that reported in other international studies (60%\u201380%). In the population with DM2 and MAFLD, we did not observe a decrease in CEC. Initially we found a slight elevation of CEC in adolescents with DM2, however, with the increase in liver fat, a little decrease is observed, which could explain a probable metabolic phenomenon, since the physicochemical composition and distribution of the particles is associated with the percentage of liver fat. A positive correlation between the percentage of liver fat and the concentration of HDL2b (\n p<\/jats:italic>\n \u2009=\u20090.011), HDL2a (\n p<\/jats:italic>\n \u2009=\u20090.014) and average particle size (\n p<\/jats:italic>\n \u2009=\u20090.011) and the proportion of triglycerides inside the particles (\n p<\/jats:italic>\n \u2009=\u20090.007). Likewise, negative correlation were found with the percentage of liver fat, cholesterol esters (\n p<\/jats:italic>\n \u2009=\u20090.010) and free cholesterol of the particles (\n p<\/jats:italic>\n \u2009&lt;\u20090.001). We observed a positive correlation between CEC and the percentage of triglycerides (\n p<\/jats:italic>\n \u2009=\u20090.007), and a negative correlation with the percentage of cholesterol esters (\n p<\/jats:italic>\n \u2009=\u20090.05) inside the HDL's particles.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In this group of adolescents with DM2, the presence of MAFLD was not associated with CEC; however, it is associated with abnormalities in the distribution and lipid composition of HDL particles. The momentum generated by the original proposal for MAFLD in the adult population and following the recommendations for pediatric MAFLD will be a step forward in helping to study the impact of MAFLD on the atheroprotective properties of HDL in the pediatric population.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fped.2024.1462406","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T23:11:18Z","timestamp":1734995478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes"],"prefix":"10.3389","volume":"12","author":[{"given":"Jos\u00e9 Antonio","family":"Orozco Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00edda Xochitl","family":"Medina Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita Torres","family":"Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Reyes Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban Jorge","family":"Galarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Gabriel","family":"Ju\u00e1rez Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Dies Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahum","family":"M\u00e9ndez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Enrique","family":"D\u00edaz Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubia","family":"Vel\u00e1zquez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Medina Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/dc16-1066","article-title":"Youth-onset type 2 diabetes consensus report: current Status, challenges, and priorities","volume":"39","author":"Nadeau","year":"2016","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2337\/dc13-1838","article-title":"Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study","volume":"37","author":"Pettitt","year":"2014","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2337\/dc13-0954","article-title":"Earlier onset of complications in youth with type 2 diabetes","volume":"37","author":"Dart","year":"2014","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/diacare.26.11.2999","article-title":"Complications in young adults with early-onset type 2 diabetes","volume":"26","author":"Hillier","year":"2003","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2337\/dc12-2420","article-title":"Rapid rise in hypertension and nephropathy in youth with type 2 diabetes","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/S0140-6736(17)31371-5","article-title":"Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden","volume":"389","author":"Viner","year":"2017","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0140-6736(07)60821-6","article-title":"Acute and chronic complications of type 2 diabetes mellitus in children and adolescents","volume":"369","author":"Pinhas-Hamiel","year":"2007","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pedi.12719","article-title":"ISPAD clinical practice consensus guidelines 2018: type 2 diabetes mellitus in youth","volume":"19","author":"Zeitler","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0973-6883(12)60102-9","article-title":"Epidemiology and natural history ofnon-alcoholic fatty liver disease","volume":"2","author":"Mishra","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in Latinos","volume":"14","author":"Saab","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2468-1253(21)00391-5","article-title":"Metabolic-associated fatty liver disease in children and adolescents: Mexican experience","volume":"6","author":"M\u00e9ndez-S\u00e1nchez","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e934134","DOI":"10.12659\/MSM.934134","article-title":"A review of the increasing prevalence of metabolic-associated fatty liver disease (MAFLD) in children and adolescents worldwide and in Mexico and the implications for public health","volume":"27","author":"Ram\u00edrez-Mej\u00eda","year":"2021","journal-title":"Med Sci Monit"},{"key":"B19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jhep.2021.04.021","article-title":"Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience","volume":"75","author":"M\u00e9ndez-S\u00e1nchez","year":"2021","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhep.2021.12.020","article-title":"Latin American Association of Pediatrics (ALAPE) endorses the MAFLD definition of fatty liver disease","volume":"77","author":"M\u00e9ndez-S\u00e1nchez","year":"2022","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11892-013-0448-y","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes in obese children","volume":"14","author":"Hecht","year":"2014","journal-title":"Curr Diab Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/dc07-zb06","article-title":"Nonalcoholic fatty liver disease and insulin resistance in youth","volume":"30","author":"Bloomgarden","year":"2007","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4291\/wjgp.v8.i2.51","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"8","author":"Patil","year":"2017","journal-title":"World J Gastrointest Pathophysiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0002-9149(00)01464-8","article-title":"High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high\u2014density lipoprotein intervention trial","volume":"86","author":"Boden","year":"2000","journal-title":"Am J Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/01.ATV.0000183727.90611.4f","article-title":"Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veterans affairs HDL intervention trial","volume":"25","author":"Asztalos","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"De la Llera-Moya","year":"2010","journal-title":"Arterioscler Thromb Vac Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1194\/jlr.R001610","article-title":"The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?","volume":"51","author":"Vergeer","year":"2010","journal-title":"J Lipid Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0926-6569(64)90215-9","article-title":"Some properties of a cholesterol esterifying enzyme in human plasma","volume":"89","author":"Glomset","year":"1964","journal-title":"Biochim Biophys Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2015.180","article-title":"HDL Abnormalities in nephrotic syndrome and chronic kidney disease","volume":"12","author":"Vaziri","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/ATVBAHA.111.240705","article-title":"Regulation of lipid droplet cholesterol efflux from macrophage foam cells","volume":"32","author":"Ouimet","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","article-title":"Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/ATVBAHA.116.307385","article-title":"Impaired cholesterol efflux capacity of high-density lipoprotein isolated from interstitial fluid in type 2 diabetes mellitus\u2014brief report","volume":"36","author":"Apro","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/pedi.13103","article-title":"Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus","volume":"21","author":"Orozco Morales","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes standards of medical care in diabetes 2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.arcmed.2009.02.009","article-title":"Increase in body mass index and waist circumference is associated with high blood pressure in children and adolescents in Mexico city","volume":"40","author":"Flores-Huerta","year":"2009","journal-title":"Arch Med Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.1986.03380170088024","article-title":"A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The lipid research clinics prevalence study","volume":"256","author":"DeLong","year":"1986","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0022-2275(20)31585-6","article-title":"A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma","volume":"42","author":"P\u00e9russe","year":"2001","journal-title":"J Lipid Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/0005-2760(81)90253-8","article-title":"Characterization of human highdensity lipoproteins by gradient gel electrophoresis","volume":"665","author":"Blanche","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J Lipid Res"},{"key":"B45","first-page":"659","article-title":"HDL-mediated cellular cholesterol efflux assay method","volume":"45","author":"Hafiane","year":"2015","journal-title":"Ann Clin Lab Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1194\/jlr.D018051","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol","volume":"52","author":"Sankaranarayanan","year":"2011","journal-title":"J Lipid Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.3748\/wjg.v20.i23.7392","article-title":"Radiologic evaluation of nonalcoholic fatty liver disease","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"B49","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.29596","article-title":"Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease","volume":"67","author":"Middleton","year":"2018","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1148\/radiol.12120896","article-title":"Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis","volume":"267","author":"Tang","year":"2013","journal-title":"Radiology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2018.07.028","article-title":"Cholesterol efflux capacity is impaired in subjects with an elevated fatty liver index, a proxy of non-alcoholic fatty liver disease","volume":"277","author":"van den Berg","year":"2018","journal-title":"Atherosclerosis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/biomedicines8120625","article-title":"HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically- but not genetically driven non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Di Costanzo","year":"2020","journal-title":"Biomedicines"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2337\/dc06-0455","article-title":"Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes","volume":"29","author":"Toledo","year":"2006","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2006.07.003","article-title":"Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus","volume":"376","author":"P\u00e9rez-M\u00e9ndez","year":"2007","journal-title":"Clin Chim Acta"},{"key":"B56","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2337\/dc07-1558","article-title":"Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions","volume":"31","author":"Kantartzis","year":"2008","journal-title":"Diabetes Care"},{"key":"B57","doi-asserted-by":"publisher","first-page":"11691","DOI":"10.1038\/s41598-018-29639-5","article-title":"Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis","volume":"8","author":"Fadaei","year":"2018","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentra- tion determinated by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"key":"B59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/biomedicines9030242","article-title":"Obesity affects HDL metabolism, composition and subclass distribution","volume":"9","author":"Stadler","year":"2021","journal-title":"Biomedicines"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1462406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T23:11:23Z","timestamp":1734995483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1462406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":59,"alternative-id":["10.3389\/fped.2024.1462406"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1462406","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"article-number":"1462406"}}